|Variation in psychosis gene ZNF804A is associated with a refined schizotypy phenotype but not neurocognitive performance in a large young male population.|
|Jump to Full Text|
|PMID: 23155182 Owner: NLM Status: MEDLINE|
|Genetic variability within the ZNF804A gene has been recently found to be associated with schizophrenia and bipolar disorder, although the pathways by which this gene may confer risk remain largely unknown. We set out to investigate whether common ZNF804A variants affect psychosis-related intermediate phenotypes such as cognitive performance dependent on prefrontal and frontotemporal brain function, schizotypal traits, and attenuated psychotic experiences in a large young male population. Association analyses were performed using all 4 available self-rated schizotypy questionnaires and cognitive data retrospectively drawn from the Athens Study of Psychosis Proneness and Incidence of Schizophrenia (ASPIS). DNA samples from 1507 healthy young men undergoing induction to military training were genotyped for 4 previously studied polymorphic markers in the ZNF804A gene locus. Single-marker analysis revealed significant associations between 2 recently identified candidate schizophrenia susceptibility variants (rs1344706 and rs7597593) and a refined positive schizotypy phenotype characterized primarily by self-rated paranoia/ideas of reference. Nominal associations were noted with all positive, but not negative, schizotypy related factors. ZNF804A genotype effect on paranoia was confirmed at the haplotype level. No significant associations were noted with central indexes of sustained attention or working memory performance. In this study, ZNF804A variation was associated with a population-based self-rated schizotypy phenotype previously suggested to preferentially reflect genetic liability to psychosis and defined by a tendency to misinterpret otherwise neutral social cues and perceptual experiences in one's immediate environment, as personally relevant and significant information. This suggests a novel route by which schizophrenia-implicated ZNF804A genetic variation may confer risk to clinical psychosis at the general population level.|
|Nicholas C Stefanis; Alex Hatzimanolis; Dimitrios Avramopoulos; Nikolaos Smyrnis; Ioannis Evdokimidis; Costas N Stefanis; Daniel R Weinberger; Richard E Straub|
|Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't Date: 2012-11-15|
|Title: Schizophrenia bulletin Volume: 39 ISSN: 1745-1701 ISO Abbreviation: Schizophr Bull Publication Date: 2013 Nov|
|Created Date: 2013-10-14 Completed Date: 2014-06-23 Revised Date: 2014-10-03|
Medline Journal Info:
|Nlm Unique ID: 0236760 Medline TA: Schizophr Bull Country: United States|
|Languages: eng Pagination: 1252-60 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Cognition Disorders / diagnosis, genetics*
Genetic Predisposition to Disease
Greece / epidemiology
Kruppel-Like Transcription Factors / genetics*
Paranoid Disorders / diagnosis, genetics
Polymorphism, Single Nucleotide
Psychiatric Status Rating Scales
Psychotic Disorders / diagnosis, genetics
Schizotypal Personality Disorder / diagnosis, genetics*
|P50 MH094268/MH/NIMH NIH HHS; R01 MH085018/MH/NIMH NIH HHS; R01 MH092515/MH/NIMH NIH HHS|
|0/Genetic Markers; 0/Kruppel-Like Transcription Factors; 0/ZNF804A protein, human|
Journal ID (nlm-ta): Schizophr Bull
Journal ID (iso-abbrev): Schizophr Bull
Journal ID (hwp): schbul
Journal ID (publisher-id): schbul
Publisher: Oxford University Press, US
© The Author 2012. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.
Print publication date: Month: 11 Year: 2013
Electronic publication date: Day: 15 Month: 11 Year: 2012
pmc-release publication date: Day: 15 Month: 11 Year: 2012
Volume: 39 Issue: 6
First Page: 1252 Last Page: 1260
PubMed Id: 23155182
|Variation in Psychosis Gene ZNF804A Is Associated With a Refined Schizotypy Phenotype but Not Neurocognitive Performance in a Large Young Male Population|
|Nicholas C. Stefanis*1-3|
|Costas N. Stefanis1|
|Daniel R. Weinberger5|
|Richard E. Straub5|
1University Mental Health Research Institute, Athens, Greece;
2Department of Psychiatry, Medical School, National and Kapodistrian University of Athens,Athens, Greece;
3School of Psychiatry and Clinical Neurosciences, The University of Western Australia and North Metropolitan Health Service—Mental Health, Perth, Australia;
4McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD;
5Lieber Institute for Brain Development, John Hopkins University School of Medicine, Baltimore, MD, USA
|Correspondence: *To whom correspondence should be addressed; Centre for Clinical Research in Neuropsychiatry, School of Psychiatry and Clinical Neurosciences, The University of Western Australia and North Metropolitan Health Service—Mental Health, Gascoyne House, John XXIII Avenue, Mt Claremont, WA 6010, Perth, Australia; tel: (08)9347-6439, fax: (08)9384-5128, e-mail: email@example.com
One of the most promising candidate genes to emerge from genome-wide association studies (GWASs) of psychosis is ZNF804A. O’Donovan et al1 undertook a GWAS of schizophrenia with follow-up in approximately 17 000 subjects comprising 2 further replication stages. Although the statistical evidence in schizophrenia was short of genome-wide significance, that threshold was surpassed when the phenotype was expanded to include bipolar disorder (P = 9.96×10–9). The T-allele of rs1344706 in ZNF804A, showing the strongest association signal with schizophrenia, also showed an association with bipolar disorder in the above study and predicted elevated manic symptomatology in an independent study,2 demonstrating that variation at this locus has an effect on illness susceptibility across the traditional diagnostic boundaries. Association between rs1344706, recently acknowledged as a functional polymorphism,3 and the broader psychosis phenotype was confirmed in a nonoverlapping large multiethnic European sample,4 although not every dataset surveyed has shown positive association.5 A recent meta-analysis of rs1344706 in all available datasets provided strong evidence for association with schizophrenia (P = 2.54×10–11) and the extended psychosis phenotype, and there was no evidence for heterogeneity across studies.6 Association with ZNF804A variants has expanded to include potentially new candidates such as rs7597593 that was found to be preferentially associated with schizophrenia in the Irish Case–Control Study of Schizophrenia.7 In a recent study, Zhang et al8 reported that the association with rs7597593 in several large public GWAS datasets may show sex modulation, being especially strong in females. Overall, there is now substantial evidence for the involvement of ZNF804A in psychosis vulnerability.
An enduring hypothesis to explain many inconsistencies in association genetic studies of schizophrenia is that risk variants may modulate intermediate phenotypes associated with increased risk for psychosis rather than the disorder itself.9 Candidate intermediate phenotypes of schizophrenia with which the disorder presumably shares a degree of overlapping genetic liability include structural and functional brain alterations, neurocognitive deficits, and enduring schizotypal personality traits. Recent evidence that ZNF804A may indeed affect intermediate cognitive phenotypes is provided by Esslinger et al,10 who demonstrated that among normal volunteers who were assessed with an established neurocognitive probe, the N-back working memory task, the rs1344706 risk allele was associated with a pattern of relatively abnormal connectivity in the human brain, including reduced connectivity within the dorsolateral prefrontal cortex (DLPFC) and decreased uncoupling between the DLPFC and hippocampus, which parallels findings with the same paradigm reported in patients with schizophrenia. Of note, the above observations were validated by other groups,11,12 supporting the modulatory role of ZNF804A in human cognitive functioning. In addition, Walter et al13 found differences in medial prefrontal and left temporoparietal cortical activations during a theory of mind task, again in healthy carriers of the common rs1344706 risk allele, and Walters et al14 have reported results with rs1344706 that further demonstrate that the inherent complexity in the relationships between genotype and phenotype will defeat overly simplistic attempts in proposing mechanisms of action. They found in 2 independent samples that the strength of the effect on clinical risk increased when patients with lower intelligence quotients (IQs) were excluded from the analysis, even though no single-nucleotide polymorphism (SNP) effect on IQ was found. These results suggested that in contrast to the postulated effects of ZNF804A on neural connectivity, variations within this gene may not be strongly associated with standard cognitive intermediate phenotypes in controls and patients with schizophrenia as they appeared to delineate an illness subtype in which cognitive deficits were not a strong feature. Recent studies in healthy individuals provide fairly clear evidence that standard structural brain endophenotypes are not targets of ZNF804A variability: For example, Donohoe et al15 found no significant rs1344706 effect on brain volumes in normal individuals, which was successfully replicated by Cousijn et al16 in a much larger sample of 892 volunteers.
Collectively, these studies highlight the lack of ZNF804A effect on general cognitive abilities and structural intermediate phenotypes, at least in healthy subjects. On the other hand, the above studies do not address the possibility that ZNF804A-related vulnerability may be mediated via alternative routes, eg, by affecting psychological rather than cognitive intermediate phenotypes, such as enduring schizotypal personality traits or subclinical psychotic experiences that are considered to be in an etiological continuity with the disorder and that are suggested to share genetic variation with the clinical phenotype.17
We first reported on the utility of adopting a population-based cognitive-psychological intermediate phenotype approach to study the potential effect of candidate susceptibility genes for schizophrenia.18 In view of recent conflicting reports, we set out to evaluate in a large cohort of healthy young males whether 4 SNP variants, and their corresponding haplotypes in the ZNF804A gene locus, affect intermediate cognitive phenotypes of schizophrenia, namely aspects of cognitive performance that exhibit a degree of heritability and are broadly dependent on prefrontal or frontotemporal brain function. We further set out to evaluate whether ZNF804A gene variations affect such schizophrenia-related psychological constructs as self-rated schizotypy and stress-induced psychotic experiences. Potential associations detected with specific schizotypy constructs/symptoms and/or cognitive performance might help elucidate and refine ZNF804A effects on the broader psychosis phenotype and add validity to the evidence of association with clinical diagnosis.
Participants at the time of data collection were undergoing a mandatory military training program at the Greek Air Force during the first 2 weeks of admission to the National Basic Air Force Training Center in Tripolis, Greece. Within the ASPIS (Athens Study of Psychosis Proneness and Incidence of Schizophrenia), 8 such consecutive separate waves of conscripts were assessed. From a total of 2130 eligible healthy young males aged 18–24 years, retrospective data were drawn from a pool of 1507 selected young male responders who had valid scores across the entire neurocognitive battery, thus biasing the sample toward participants with an increased acceptance rate of the procedures. All conscripts had received a standardized screening interview by a team of military doctors of different specialties in order to exclude serious medical conditions, including documented diagnosis of psychotic disorders and substance dependence. Military service is compulsory in Greece, and all healthy men are recruited and assigned to the different army corps by random assignment. All the individuals included in this study were of Greek family background (both parents of Greek origin).
Within the first 2 weeks of military induction, conscripts completed a psychometric battery of self-administered questionnaires The assessment battery included assessment of (a) lifetime schizotypal personality traits, with the Schizotypal Personality Questionnaire (SPQ),19–21 (b) unusual body perceptual experiences, with the Perceptual Aberration Scale (PAS)22, (c) attenuated psychotic experiences, with the Community Assessment of Psychic Experiences (CAPE)23 and (d) an index of stressed-induced psychotic symptoms, with the combined psychosis score from the Symptom Checklist 90-Revised (SCL90R).24,25 The SPQ is a 74 “yes-no” item questionnaire that assesses 9 aspects of the Schizotypal Personality Disorder (SPD) according to the Diagnostic and Statistical Manual of Mental Disorders (Revised).27 Analysis of the factorial structure of the SPQ as defined by the responses of this sample has been achieved through confirmatory factor analysis (CFA), which indicated that the best fit to the data was provided by a 4-factor model, comprising Positive, Negative, Disorganization, and Paranoid factors.20 This 4-factorial model of schizotypy has been recently replicated by other research groups,26 and importantly, high SPQ scorers in this conscript sample were predictive of an independent diagnosis of Schizotypal Personality Disorder upon SCID II interview.21 The CAPE is a 40-item, self-rated questionnaire, allowing for a 4-scaled response to the lifetime presence of a broad range of “toned down” psychosis symptoms. It has a 3-factor structure of positive, negative, and depression dimensions extracted from the CFA. The original validation study of this schizotypy instrument was based on this conscript population.23
The PAS is a 35-item, yes-no, self-rated questionnaire. The SCL90R is a comprehensive “state” self-report questionnaire of 90 questions, which covers a broad range of psychiatric symptoms experienced within the previous 2 weeks. We combined the scores of “paranoid ideation” and “psychoticism” subscales into a mean total score (hereafter “psychosis” score). This was also done in previous publications that used this composite variable as a proxy measure of psychosis proneness in the general population.25,28 The study was approved by the Bioethics and Medical Deontology Committee of the University Mental Health Research Institute.
Conscripts underwent an extensive interview of computerized neurocognitive abilities. We chose to include in this study those available cognitive measures related broadly to prefrontal and frontotemporal brain function, namely, sustained attention, with the Continuous Performance Task-Identical Pairs version (CPT-IP)29 and verbal and spatial working memory, with the Ν-back task.30 In accordance with our previous work, we a priori decided to exclude data from further analyses if the central index of performance (d′) on CPT-IP and 2-back was <0 and if there were ≥3 unsuccessful trials (of 5) for verbal and spatial 2-back tasks.
After written informed consent was obtained, mouthwash samples for DNA extraction were selected as described previously.31 Four common (minor allele frequency, MAF > 0.2) SNPs within the ZNF804A gene locus were chosen for genotyping from among the 1507 selected young male conscripts. The SNPs were rs7597593, rs1344706, rs4667001, and rs3731834. Marker rs1344706 was originally associated with schizophrenia in a GWAS by O’Donovan et al.1 We selected rs7597593 from the study of Riley et al7 because it provided the strongest association in the Irish Case–Control Study of Schizophrenia. The G-allele at rs4667001 (missense SNP) was associated with an increase in ZNF804A expression.6 Genotyping was performed using Taqman 5′-exonuclease allelic discrimination assays (Applied Biosystems). Genotype reproducibility was routinely assessed by re-genotyping 10% of the samples and was generally >99%.
We quantified the preselected psychometric and neuro cog ni tive central indexes of performance as continuous dependent variables. We assessed separately the 4 schizotypal latent factors (or dimensions) of SPQ and the positive and negative CAPE factors23 that emerged from applying CFA to this dataset.20,23 We opted to examine post hoc potential association with individual SPQ subscales or CAPE items, only if convincing signals of association emerged across the ZNF804A locus with any of the latent constructs derived from CFA. Genotypic compliance with the Hardy-Weinberg law was assessed with an exact test. In our sample, SPQ, SCL90R “psychosis” score, and all cognitive scores were normally distributed and analyzed with linear regressions. We examined whether the number of minor allele copies was associated with each quantitative outcome (allele-load or allele-based additive models), using PLINK software v1.07 (http://pngu.mgh.harvard.edu/~purcell/plink/).32 PAS as well as CAPE positive and negative symptom subscales were log-transformed before analysis due to deviation from normality. However, individual CAPE items were skewed and therefore nonparametric Kruskal-Wallis tests were utilized as appropriate. In our single-SNP analyses, we corrected for multiple comparisons tested (11 phenotypes ×4 SNPs) by applying the false discovery rate (FDR) procedure according to Benjamini and Hochberg,33 allowing for 5% false-positive results (significant association if PFDR < .05). We note, however, that the FDR correction could be considered overly conservative in this dataset given the nonindependence between the statistical tests performed, due to high correlations between the phenotypic outcomes and the SNPs analyzed (supplementary tables S1, S2). Furthermore, all significant associations in the allele-load regression analysis were individually confirmed by nonparametric permutation testing in order to minimize plausible spurious effects. Further, 2- and 3-marker haplotypes were reconstructed in PLINK, which uses the expectation-maximization algorithm to estimate haplotype structures and their frequencies. Only haplotypes with frequency >1% were considered for further analysis. The effect of each haplotype was tested using linear models and empirical significance was obtained by performing 10 000 permutations of the data (Max(T) procedure in PLINK). The main analyses did not adjust for nongenetic factors. However, in a post hoc analysis, we adjusted for age, IQ, and their interaction. Given the sample size and an additive genetic model, we have sufficient power (80%) to detect genotype effects that may explain individual differences in phenotypic variance of R2 = 0.012.
The mean age of the individuals was 21.0 years (SD = 1.9), and mean number of years of schooling was 13.0 years (SD = 2.0). In total, 1507 healthy young male conscripts were genotyped for the 4 previously studied SNPs within the ZNF804A gene locus. Marker characteristics and genotype information for each marker are summarized in table 1. Genotype frequencies for each SNP studied were not deviant from those expected for genotypes in Hardy-Weinberg equilibrium (all P > .3). As depicted in supplementary table S1, based on D′ values, moderate to high levels of linkage disequilibrium (LD) were observed between rs1344706 and rs7597593 markers (r2 = 0.32) and between rs1344706 and rs4667001 (r2 = 0.427). However, marker rs3731834 showed negligible LD correlation with the other 3 markers in our sample (r2 < 0.13) and, thus, we did not include it in subsequent haplotype association analysis. For each marker tested, there was no difference between demographic variables and ZNF80A genotype status (t test P > .1).
As shown in table 2, our primary allele-load regression analysis showed that 2 ZNF804A SNPs were significantly associated with the SPQ paranoid schizotypy factor: rs7597593 (β = –.03, R2 = 0.013, P = .00008, corrected PFDR = .004) and rs1344706 (β = .026, R2 = 0.009, P = .0009, corrected PFDR = .02). Furthermore, we detected an individual nominally significant effect of the originally GWAS-identified SNP rs1344706 on SPQ disorganization factor (β = .022, P = .009, corrected PFDR = .081). No association was observed with the “core” positive and negative SPQ schizotypy factors. In a post hoc regression analysis on SPQ subscales that loaded on the SPQ paranoid factor20, we noted that the association between ZNF804A variants and paranoia was driven mainly by the SPQ “ideas of reference” subscale and was markedly stronger for rs7597593, compared to the other 3 markers located at the 3′ end (β = –.04; R2 = 0.014, PFDR = .003).
In line with the results obtained from SPQ, individuals carrying the major allele C for the most prominent marker rs7597593 exhibited nominally significant elevated scores in both psychosis-related phenotypes PAS and CAPE positive factor (β = –.028; P = .009 for PAS; β = –.011; P = .0097 for CAPE positive factor), showing an association trend after correcting for multiple comparisons (PFDR = .081; table 2). Notably, in the subsequent exploratory analysis and in agreement with the effect of rs7597593 on SPQ paranoia/ideas of reference, rs7597593 effect on positive CAPE factor (18 items) was driven by associations with 2 items related to a conceptually similar phenotype: “Do you ever feel as if things in magazines or on TV were written especially for you?” (P = .002); and “Do you ever feel as if you are being persecuted in some way?” (P = .003). However, in our single-marker analysis, the 2 previously reported psychosis risk alleles, (A) at rs7597593 and (T) at rs1344706, were associated with decreased scores in SPQ factors as well as the PAS and CAPE positive factor, apparently exhibiting a “protective” rather than “risk” effect. Regarding the effect of ZNF804A variants on stress-induced psychotic symptoms, as indexed by the SCL90R combined psychosis score, none of the variants showed convincing evidence of association, although rs1344706 was nominally associated (P = .035) with this “positive” psychosis index. Similarly, no associations could be observed with any of the cognitive measures included in this study (table 3.
Table 4 shows the 2- and 3-marker haplotype frequencies found in this Greek population, as well as the individual association results. Haplotype analyses yielded results generally consistent with the single-SNP analyses and did not provide much additional insight on certain “risk” allele combinations. Specifically, when the 4 SPQ schizotypy factors were explored, only the paranoid factor score was significantly associated with ZNF804A haplotype variability. Similarly, nominal associations were also observed for PAS and CAPE positive factor (data available upon request). As seen in table 4, individuals carrying the rs7597593-C, rs1344706-C, and rs4667001-A alleles (CCA haplotype) expressed significantly elevated SPQ paranoid factor scores (β = .027, adjusted P = .005 after 10 000 permutations) compared with the carriers of the complementary psychosis risk alleles (TAG haplotype), who demonstrated a fairly “protective” effect against paranoid features (adjusted P = .01). These effects remained similar when age, IQ, and their interaction were entered as confounding factors in our model. Furthermore, to disentangle whether the 2 significantly associated markers (rs7597593, rs1344706) in our single-SNP analysis represent independent effects or whether they reflect the same signal due to LD, a 2-SNP conditional haplotype analysis was performed. The haplotype association with SPQ paranoid factor disappeared when conditioned on rs7597593 (P = .68) but remained significant when conditioned on rs1344706 (P = .022), indicating that the observed genetic effect was actually driven by rs7597593.
We report a significant association between ZNF804A, a strong candidate gene for psychosis with a refined “positive” schizotypy phenotype primarily encompassing paranoia/ideas of reference, in a large cross-sectional study of 1507 young male conscripts undergoing initiation to military service. First, at the single-marker level of analysis, highly significant association was detected between 2 out of 4 tested ZNF804A variants and the paranoid schizotypy factor derived from confirmatory factor analysis of the SPQ. The strongest detected signal was between rs7597593 and the SPQ paranoid factor, surviving a stringent correction for multiple hypothesis testing. The association with paranoia for both the schizophrenia susceptibility SNPs, rs7597593 and rs1344706, was mainly attributable to association with the SPQ “ideas of reference” subscale (best P = 5×10–5, uncorrected). The ZNF804A association with paranoia was confirmed at the haplotype level. Interestingly, both schizophrenia candidate susceptibility SNPs were simultaneously nominally associated with perceptual aberrations, indicating that ZNF804A variability may also be tagging a schizotypy phenotype associated with spatial and temporal unity of self, considered a core feature of schizophrena liability.34,22 Additionally, the genome-wide psychosis implicated marker rs1344706 was associated with the paranoid state and also showed a trend association (FDR-corrected P = .08) with the SPQ disorganization factor. The above finding partially replicates a recent report in which, however, paranoid traits were not separately investigated.35 In line with the above findings, it is also worth noting that a recent report implicated the same rs1344706 risk allele to elevated personalizing bias (tendency to blame others) among normal volunteers, which represents a behavioral trait closely related to paranoid ideation.36 Our results might be viewed as supplementary to the GWAS results from O’Donovan et al,1 which revealed genome-wide association of psychosis to the ZNF804A locus, as it perhaps further refines the phenotypic effects of the gene. We hypothesize that positive schizotypal traits such as paranoia/ideas of reference, psychological features traditionally linked with genetic vulnerability to psychosis,37 may be an important phenotypic target of ZNF804A variability. Furthermore we propose that ZNF804A variability complements at the molecular level previous psychometric studies utilizing the SPQ in relatives of patients, which demonstrated consistently that ideas of reference best reflect the genetic liability to schizophrenia.38–40 We acknowledge, however, that only prospective studies will be able to decipher whether this ZNF804A-driven route of presumed vulnerability actually mediates transition to clinically defined psychosis.
Second, we demonstrate here that the genetic associations with the examined schizotypy-related outcomes were mainly attributable to rs7597593, because the effect of rs1344706 was shown to arise from its high correlation with rs7597593. Notably, similar observations were made by Riley et al7 with the clinical phenotype in the Irish Case–Control Study of Schizophrenia and by Zhang et al8 in a large case–control analyses from public GWAS datasets. Also, as shown by Williams et al,6 rs1344706 remained the most strongly associated marker tested in the gene after sequencing exonic regions in and around it, but rs7597593 was not typed in that study. The above findings perhaps suggest that multiple biologically active genetic variants are located toward the 5′ end of the gene and that more detailed sequencing efforts of affected individuals is warranted. Furthermore, rs7597593, which is not covered by the Affymetrix genome-wide 6.0 array, and thus not reported upon in previous GWASs, was suggestively associated in this study with positive rather than negative aspects of schizotypy across most of self-rated schizotypy questionnaires and with the same allele directionality. It would be difficult to dismiss these phenotypes—consistent signals of association—on the basis of potential type I error or due to the psychometric properties of any individual self-rated schizotypy scale. On the contrary, we propose that they may be viewed as providing convergence and discriminant validity for rs7597593 affecting a common underlying aspect of positive schizotypy, which is related to ideas of reference and perceptual distortions. Further item-to-item exploratory and confirmatory factorial analysis could be attempted in the future in order to further refine the phenotypes associated with rs7597593 and rs1344706.
ZNF804A SNPs and haplotypes were not associated with our measures of sustained attention and working memory ability, thus adding to the accumulating evidence that standard neurocognitive-intermediate phenotypes dependent on the integrity of prefrontal and frontotemporal function are probably not a major target of ZNF804A variability, at least amongst healthy individuals. Nevertheless, the lack of functional–imaging-data acquisition in this cohort prohibits us from reporting on the possibility that functional imaging intermediate phenotypes are suitable targets of ZNF804A variability, as suggested by other groups.10
Despite the fact that the association with paranoid traits withstands a multiple-testing correction, the allelic direction of association was opposite to what we expected and is, at least on the surface, somewhat counterintuitive. Previously identified risk-associated alleles of rs7597593 (T) and rs1344706 (A) were, in this study, associated with a significant reduction rather than increase in all instruments of positive schizotypy used, both in the single-SNP and haplotype analyses. In order to exclude possible technical issues in genotyping procedure, which could explain the above observation, we a posteriori obtained external validation of our results by typing marker rs1344706 in an independent laboratory (Erasmus Center, Rotterdam, data available upon request), obtaining identical directionality and significance level. The observation of opposing associated alleles is, however, a relatively frequent phenomenon, especially when studying populations with different genetic backgrounds.41,42 Explanations for this phenomenon include differences in LD with reverse correlation coefficients, with a causal variant at another locus or interactive effects with other genomic variants that carry different common alleles in different populations (in this case, Greek vs northern European). As demonstrated recently, the impact of a specific genetic variant on a phenotype may depend on the genetic background of the population, the constellation of many other variants with small effects across the genome. Studies on intellectual disability and autism have shown that normal synaptic function happens within a range of glutamate receptor protein synthesis and that genetic variation tipping the balance in either direction can result in the same deleterious effect, in this case, autism.43 A consequence of this result is that a mild effect that increases protein synthesis would be beneficial if the population average is slightly closer to the low side of the balance and deleterious in the opposite case. This is one concrete example on how allelic alterations that increase risk in one population could be protective in another. It is possible that this or other mechanisms could be the explanation for our results. This allele reversal likely represents an indirect indication that other tagged causal variants that cannot be detected in conventional association studies are truly responsible for the observed association in our study and also in previous reports that examined the same common markers. Furthermore, as Clarke and Cardon42 have shown, the probability of observing a significant allele flip is negligible when an allele flip is not genuine. Alternatively, this significant allele flip may suggest that at the subclinical level, ZNF804A genotype exerts a rather protective effect that plausibly becomes a true predisposition factor in clinical states where additional genetic alterations/defects are present. However, a replication attempt in an independent sample from the same population would possibly resolve this issue and help disentangle whether this is a spurious finding.
Along these lines, we acknowledge that, several, if not all, of the identified signals in our study might still be false positives and thus the interpretation of the modestly significant associations should be conservative. However, our primary aim was to target variants of a gene that already had some direct support for involvement in the pathogenesis of schizophrenia and therefore the prestudy probability of significant associations was not negligible as in a hypothesis-free, discovery-oriented approach. Consequently, the multiplicity of comparisons is far less than implied at first sight. While 3 of the 4 SNPs are now considered functional or lead to conservative amino acid substitutions, it is likely that the bulk of the signal is due to multiple unobserved causal variants in LD with the 2 (rs7597593, rs1344706) intronic SNPs that showed the strongest association in this study.
These results can be viewed as providing further support for at least some overlapping genetic underpinnings for the subclinical and clinical manifestations of psychosis. In conclusion, we report here that particular aspects of “positive” schizotypy rather than aspects of cognitive function may serve as targets of ZNF804A variation. The refined phenotype most sensitive to ZNF804A variability is characterized by ideas of reference and suggestively of distortion of perceptual experiences, which bears a striking resemblance to “aberrant salience”44, the process hypothesized to underlie the formation of delusions and hallucinations. Based on this apparent similarity we can only speculate that ZNF804A, a gene strongly associated with clinical psychosis and derived “atheoretically” by GWAS, may mediate risk by indirectly impacting on a tendency to misconstrue external/internal cues which is arguably central to the psychosis experience. This is reflected by the clinically unobservable or covert effects of ZNF804A variation at the population level. This work also may offer further support for the strategy of adopting subclinical, population-based phenotypes and cognitive intermediate phenotypes in order to explore the genetic underpinnings of clinical psychosis. Further prospective and case–control studies that may incorporate more detailed molecular examination of ZNF804A gene modulation are encouraged in order to validate the results reported herein.
Supplementary material is available at http://schizophre niabulletin.oxfordjournals.org.
General Secretariat of Research and Technology of the Greek Ministry of Development (EKBAN 97) to Prof. Costas N. Stefanis; the Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States.
Click here for additional data file (supp_sbs110_Stefanis_Suppl.doc)
This project was supported by the European Community’s Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). Intrasoft provided the technical support for this study. The authors have declared that there are no conflicts of interest in relation to the subject of this study.
|1..||O’Donovan MC,Craddock N,Norton N,et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet.. Year: 2008;40:1053–105518677311|
|2..||Cummings E,Donohoe G,McDonald C,et al. Clinical symptomatology and the psychosis risk gene ZNF804A. Schizophr Res. Year: 2010;122:273–27520538430|
|3..||Hill MJ,Bray NJ. Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A. Mol Psychiatry. Year: 2011;16:787–78921358713|
|4..||Steinberg S,Mors O,Borglum AD,et al. ; Genetic Risk and Outcome in PsychosisExpanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry. Year: 2011;16:59–6620048749|
|5..||Schanze D,Ekici AB,Gawlik M,Pfuhlmann B,Reis A,Stöber G. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Am J Med Genet B Neuropsychiatr Genet. Year: 2011;156:198–20321302348|
|6..||Williams HJ,Norton N,Dwyer S,et al. Molecular Genetics of Schizophrenia Collaboration (MGS) International Schizophrenia Consortium (ISC), SGENE-plus, GROUPFine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry. Year: 2011;16:429–44120368704|
|7..||Riley B,Thiselton D,Maher BS,et al. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry. Year: 2010;15:29–3719844207|
|8..||Zhang F,Chen Q,Ye T,et al. Evidence of sex-modulated association of ZNF804A with schizophrenia. Biol Psychiatry. Year: 2011;69:914–91721349497|
|9..||Gottesman II,Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. Year: 2003;160:636–64512668349|
|10..||Esslinger C,Walter H,Kirsch P,et al. Neural mechanisms of a genome-wide supported psychosis variant. Science. Year: 2009;324:60519407193|
|11..||Paulus FM,Krach S,Bedenbender J,et al. Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity [published online ahead of print October 31, 2011]. Hum Brain Mapp. Year: doi:10.1002/hbm.21434.|
|12..||Rasetti R,Sambataro F,Chen Q,Callicott JH,Mattay VS,Weinberger DR. Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry. Year: 2011;68:1207–121721810628|
|13..||Walter H,Schnell K,Erk S,et al. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry. Year: 2011;16:462–47020231838|
|14..||Walters JT,Corvin A,Owen MJ,et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry. Year: 2010;67:692–70020603450|
|15..||Donohoe G,Rose E,Frodl T,et al. ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. Neuroimage. Year: 2011;54:2132–213720934520|
|16..||Cousijn H,Rijpkema M,Harteveld A,et al. Schizophrenia risk gene ZNF804A does not influence macroscopic brain structure: an MRI study in 892 volunteers [published online ahead of print January 24, 2012]. Mol Psychiatry. Year: doi:10.1038/mp.2011.181.|
|17..||Kelleher I,Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med. Year: 2011;41:1–620624328|
|18..||Stefanis NC,Trikalinos TA,Avramopoulos D,et al. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry. Year: 2007;62:784–79217336946|
|19..||Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. Year: 1991;17:555–5641805349|
|20..||Stefanis NC,Smyrnis N,Avramopoulos D,Evdokimidis I,Ntzoufras I,Stefanis CN. Factorial composition of self-rated schizotypal traits among young males undergoing military training. Schizophr Bull. Year: 2004;30:335–35015279051|
|21..||Stefanis N,Vitoratou S,Ntzoufras I,Smyrnis N,Evdokimidis I,Stefanis C. Psychometric properties of the Greek version of the Schizotypal Personality Questionnaire (SPQ) in young male obligatory conscripts: a two years test–retest study. Pers Individ Dif.. Year: 2006;41:1275–1286|
|22..||Chapman LJ,Chapman JP,Raulin ML. Body-image aberration in schizophrenia. J Abnorm Psychol. Year: 1978;87399–407681612|
|23..||Stefanis NC,Hanssen M,Smirnis NK,et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. Year: 2002;32:347–35811866327|
|24..||Derogatis R. Symptom Checklist-90-R (SCL-90-R).. Minneapolis, MN: Computer Systems; Year: 1993|
|25..||Stefanis NC,Henquet C,Avramopoulos D,et al. COMT Val158Met moderation of stress-induced psychosis. Psychol Med. Year: 2007;37:1651–165617640440|
|26..||Compton MT,Goulding SM,Bakeman R,McClure-Tone EB. Confirmation of a four-factor structure of the Schizotypal Personality Questionnaire among undergraduate students. Schizophr Res. Year: 2009;111:46–5219278834|
|27..||Spitzer RL,Williams JB,Gibbon M,First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. Year: 1992;49:624–6291637252|
|28..||Dominguez MD,Wichers M,Lieb R,Wittchen HU,van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull. Year: 2011;37:84–9319460881|
|29..||Cornblatt BA,Risch NJ,Faris G,Friedman D,Erlenmeyer-Kimling L. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. Year: 1988;26:223–2383237915|
|30..||Smyrnis N,Avramopoulos D,Evdokimidis I,Stefanis CN,Tsekou H,Stefanis NC. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biol Psychiatry. Year: 2007;61:845–85317123481|
|31..||Avramopoulos D,Stefanis NC,Hantoumi I,Smyrnis N,Evdokimidis I,Stefanis CN. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry. Year: 2002;7:706–71112192614|
|32..||Purcell S,Neale B,Todd-Brown K,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. Year: 2007;81:559–57517701901|
|33..||Benjamini Y,,Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc.. Year: 1995;57:289–300|
|34..||Lenzenweger MF. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: an update. Schizophr Bull. Year: 1994;20:121–1358197410|
|35..||Yasuda Y,Hashimoto R,Ohi K,et al. Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene. Neurosci Lett. Year: 2011;495:216–22021457757|
|36..||Hargreaves A,Morris DW,Rose E,et al. ZNF804A and social cognition in patients with schizophrenia and healthy controls. Mol Psychiatry. Year: 2012;17:118–11921876541|
|37..||Kety SS,Wender PH,Jacobsen B,et al. Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry. Year: 1994;51:442–4558192547|
|38..||Yaralian PS,Raine A,Lencz T,et al. Elevated levels of cognitive-perceptual deficits in individuals with a family history of schizophrenia spectrum disorders. Schizophr Res. Year: 2000;46:57–6311099886|
|39..||Vollema MG,Sitskoorn MM,Appels MC,Kahn RS. Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia?Schizophr Res. Year: 2002;54:39–4511853977|
|40..||Kremen WS,Faraone SV,Toomey R,Seidman LJ,Tsuang MT. Sex differences in self-reported schizotypal traits in relatives of schizophrenic probands. Schizophr Res. Year: 1998;34:27–379824874|
|41..||Lin PI,Vance JM,Pericak-Vance MA,Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet. Year: 2007;80:531–53817273975|
|42..||Clarke GM,Cardon LR. Aspects of observing and claiming allele flips in association studies. Genet Epidemiol. Year: 2010;34:266–27420013941|
|43..||Auerbach BD,Osterweil EK,Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature. Year: 2011;48063–6822113615|
|44..||Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. Year: 2003;16013–2312505794|
ZNF804A Single-Nucleotide Polymorphisms (SNPs) Analyzed and Genotype Frequencies in the ASPIS Study
|SNP ID (dbSNP)||rs7597593||rs1344706||rs4667001||rs3731834|
|Intermarker distance (bp)||0||244.848||23.319||1.617|
|Minor allele frequency (MAF)||0.372||0.381||0.401||0.216|
|HWE exact test P value||.618||.351||.483||.821|
Note: HWE, Hardy-Weinberg Equilibrium; dbSNP, marker reference number according to NCBI/SNP build 131 database.
Single-Marker Linear Regression Association Results With Psychosis-Related Traits (n = 1507)
|Phenotype||Beta||P value||Beta||P value||Beta||P value||Beta||P value|
|Ideas of reference||−.04||.00005(.003)||.032||.001(.02)||−.022||.072||.027||.053|
Note: SPQ, Schizotypal Personality Questionnaire; PAS, Perceptual Aberration Scale; CAPE, Community Assessment of Psychic Experiences; SCL90R, Symptoms Checklist 90-Revised. FDR-corrected P values for multiple comparisons are shown in bold.
Association Results With Cognitive Performance Indexes
|Sustained Attention (CPT-IP task)||Verbal Working Memory (N-Back Task)||Spatial Working Memory (N-Back Task)|
|SNP ID||Beta||P Value||Beta||P Value||Beta||P Value|
Individual Haplotype Association Results Using SPQ Paranoid Factor as the Phenotypic Outcome
|SNPs||Haplotype||Freq (%)||Beta||Nominal P Value||Adjusted P Valuea|
Note: Only significant P values (<.05) are shown in bold; ns, nonsignificant.
aAdjusted P values after running 10 000 permutations.
Keywords: Key words: schizophrenia, aberrant salience, schizotypy, paranoia, psychosis, ZNF804A.
Previous Document: Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolite...
Next Document: Neurophysiological evidence of corollary discharge function during vocalization in psychotic patient...